Medication Conversations to Reduce Falls in Geriatric Patients
This performance improvement activity is part of a statewide effort among members of the Wisconsin Geriatric Education Center (WGEC) and three of its Partners: Aurora Health Care, Medical College of Wisconsin, and the University of Wisconsin-Madison School of Medicine and Public Health.
The course is supported in part by a HRSA Geriatrics Workforce Enhancement Program award to WGEC - Marquette University with a subcontract to the Medical College of Wisconsin (HRSA Grant #U1QHP28712).
ABMS MOC IV Credit is earned through activity participation in this activity, which includes:
- Provide direct or consultative care to patients as part of the QI project.
- Implement the project’s interventions (the changes designed to improve care) and reflect on the tools you selected to see if they are the correct tools to make a change.
- Collect, submit and review data in keeping with the project’s measurement plan with two linked cycles of data review.
- Collaborate by actively discussing what you have learned with at least two people.
Primary Care Physicians, Residents, Physician Assistants, Nurse Practitioners
- Recognize the role primary care physicians play in the prescribing of benzodiazepines, non-benzodiazepine hypnotics, and diphenhydramine to geriatric patients.
- Link the use of benzodiazepines, non-benzodiazepine hypnotics, and diphenhydramine to falls among geriatric patients.
- Identify barriers and biases related to initiating medication deprescribing discussions in the primary care setting.
- Cite evidence that brief patient education on medication and falls can increase patients’ willingness to taper/discontinue use of benzodiazepines, non-benzodiazepine hypnotics, and diphenhydramine.
- Educate geriatric patients re: likelihood of benzodiazepines, non-benzodiazepine hypnotics, and diphenhydramine being associated with falls and their consequences as impacting patients’ function and quality of life.
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 20 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 20 ANCC contact hours.
The University of Wisconsin–Madison School of Nursing is Iowa Board of Nursing provider 350.
American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20 Medical Knowledge and Practice Assessment MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 2.0 continuing education units (CEUs) or 20 hours.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison ICEP, that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s).
Disclosure: No faculty, presenters, planners or others in control of content have any relevant financial relationships to disclose.
- 20.00 ABIM MOC Part 2 Points
- 20.00 AMA PRA Category 1 Credit™
- 20.00 ANCC Contact Hours
Free, current version of Internet Explorer, Firefox, Safari, or Chrome. Some older browsers and Microsoft Edge could produce error messages or not display the content correctly.
Free, current version of Adobe Acrobat Reader or other .pdf reader.
Microsoft Excel or other spreadsheet software that can open .xlsx files.